Skip to main content

Global Navigation

  • Other sites:
  • ECDC
  • European Antibiotic Awareness Day
  • ESCAIDE - Scientific conference
  • Eurosurveillance journal
  • EVIP - Vaccination portal
European Centre for Disease Prevention and Control

European Centre for Disease Prevention and Control

An agency of the European Union

Main Navigation

  • Home
  • All topics: A to Z

Secondary Navigation

  • News & events
  • Publications & data
  • Tools
  • About us
  • Search
  1. Home
  2. Publications & data
Filter by
  • Filter by
  • Infectious disease
    • Vaccine preventable diseases (2938)
    • Respiratory diseases (1856)
    • Influenza (1158)
    • Mosquito-borne diseases (1062)
    • Food- and waterborne diseases (915)
    • Zoonosis (835)
    • Measles (693)
    • West Nile virus infection (652)
    • Sexually transmitted infections (522)
    • Tuberculosis (496)
    • Influenza in humans, seasonal (432)
    • Seasonal influenza (432)
    • Flu (432)
    • Rubella (387)
    • German measles (387)
    • Viral haemorrhagic fever (362)
    • Poliomyelitis (327)
    • HIV infection (298)
    • Human immunodeficiency virus infection (298)
    • Acquired immunodeficiency syndrome (AIDS) (298)
    • Dengue (287)
    • Viral hepatitis (287)
    • Ebola haemorrhagic fever (277)
    • Vector organisms (261)
    • Zoonotic influenza (239)
    • Avian influenza virus (228)
    • Middle East respiratory syndrome coronavirus (223)
    • Chikungunya virus disease (214)
    • Influenza A (H1N1) (214)
    • Healthcare-associated infections (202)
    • Coronavirus (199)
    • Influenza A (H1N1)2009 (197)
    • Salmonellosis (194)
    • COVID-19 (184)
    • SARS-CoV-2 (184)
    • Hepatitis A (168)
    • Nosocomial infections (128)
    • Tick-borne diseases (118)
    • Zika virus disease (113)
    • Cholera (111)
    • Legionnaires’ disease (107)
    • Mosquitoes (107)
    • Yellow fever (100)
    • Hepatitis B (99)
    • Ebola outbreak - North Kivu, Ituri, DRC (96)
    • Malaria (92)
    • Escherichia coli infection (90)
    • Campylobacteriosis (88)
    • Listeriosis (85)
    • Sandfly (84)
    • Phlebotomus (84)
    • Hepatitis C (83)
    • Influenza in humans, avian origin (81)
    • Influenza A (H9N2) (80)
    • Gonorrhoea (77)
    • Avian influenza in humans (72)
    • Shiga toxin producing Escherichia coli (STEC) infection (65)
    • Verocytotoxigenic Escherichia coli (VTEC) infection (65)
    • Multidrug-resistant tuberculosis (65)
    • Verotoxigenic Escherichia coli infection (65)
    • Hepatitis (62)
    • Ticks (61)
    • Syphilis (56)
    • Pneumococcal disease (56)
    • Invasive pneumococcal disease (56)
    • Streptococcus pneumoniae (56)
    • S. pneumoniae (56)
    • Chlamydia infection (53)
    • Whooping cough (52)
    • Invasive meningococcal disease (52)
    • Meningococcal disease (52)
    • Tick-borne encephalitis (TBE) (52)
    • Pertussis (52)
    • Vector-borne disease (49)
    • Influenza in humans, pandemic (47)
    • Botulism (44)
    • Diphtheria (44)
    • Hospital-acquired infections (43)
    • Influenza in humans, swine origin (41)
    • Enterohaemorrhagic Escherichia coli (EHEC) infection (40)
    • Shigellosis (39)
    • Anthrax (38)
    • Cryptosporidiosis (38)
    • Yersiniosis (37)
    • Crimean-Congo haemorrhagic fever (34)
    • Influenza A(H7N9) virus (34)
    • Plague (33)
    • Leptospirosis (33)
    • Mumps (33)
    • Emerging disease (33)
    • Zika virus disease - Outbreak in the Americas (33)
    • Trichinellosis (32)
    • Invasive Haemophilus influenzae disease (32)
    • Haemophilus infection (32)
    • Haemophilus influenzae type b (HiB) infection (32)
    • Community acquired infections (31)
    • Giardiasis (31)
    • Ebola outbreak - West Africa (31)
    • Brucellosis (30)
    • Vibrio (29)
    • Ebola outbreak - Equateur province, DRC (29)
    • Rift Valley fever (28)
    • Enterovirus (28)
    • Coxsackievirus (28)
    • Cutaneous warts (27)
    • Influenza A(H5N1) virus (27)
    • Hydatidosis (27)
    • Human papillomavirus infection (27)
    • Echinococcosis (27)
    • Rabies (26)
    • Q fever (24)
    • Norovirus infection (24)
    • Tularaemia (23)
    • Tetanus (22)
    • Marburg haemorrhagic fever (22)
    • Clostridium difficile infection (22)
    • Marburg virus diseases (22)
    • Paratyphoid fever (21)
    • Foodborne diseases (21)
    • Enteric fever (21)
    • Typhoid and paratyphoid fever (21)
    • Hepatitis E (19)
    • Surgical site infections (19)
    • Carbapenem-resistant Enterobactericae (19)
    • Lassa fever (18)
    • Haemorrhagic fever with renal syndrome (Puumala caused) (18)
    • Nephropathia epidemica (18)
    • Hantavirus infection (18)
    • Chickenpox (17)
    • Varicella (17)
    • Severe acute respiratory syndrome (SARS) (16)
    • Lyme disease (16)
    • Borreliosis (16)
    • Toxoplasmosis, congenital (16)
    • Lymphogranuloma venereum (15)
    • Infections in long-term care facilities (15)
    • Swine-origin influenza (15)
    • Latent tuberculosis infection (15)
    • Travel related infections (14)
    • Gastrointestinal disease (14)
    • Congenital syphilis (13)
    • Syphilis, congenital (13)
    • Extensively drug-resistant tuberculosis (XDR-TB) (13)
    • Drug-resistant tuberculosis (13)
    • Smallpox (13)
    • Variant Creutzfeldt-Jakob disease (vCJD) (12)
    • Creutzfeldt-Jakob disease (12)
    • Influenza A(H5N8) virus (12)
    • Congenital rubella (11)
    • Infections in intensive care units (11)
    • Klebsiella pneumoniae (11)
    • Haemorrhagic fever (10)
    • Snail fever (9)
    • Bilharziasis (9)
    • Schistosomiasis (9)
    • Extrapulmonary tuberculosis (9)
    • Mycobacterium chimaera (8)
    • Infections in acute care hospitals (8)
    • Influenza A(H5N2) virus (8)
    • Biting midge (8)
    • Sandfly-borne diseases (7)
    • Methicillin-resistant Staphylococcus aureus (MRSA) (7)
    • Guillain-Barré syndrome (7)
    • Influenza A(H5N6) (7)
    • Monkeypox (6)
    • Disease vector (6)
    • Louse-borne diseases (6)
    • Rotavirus infection (6)
    • Leishmaniasis (6)
    • Waterborne diseases (5)
    • Schmallenberg virus (4)
    • Acinetobacter (4)
    • Japanese encephalitis virus (3)
    • Tick-borne relapsing fever (3)
    • Febris recurrens (2)
    • Candida auris (2)
    • Arenavirus (2)
    • Rickettsiosis (2)
    • Louse borne relapsing fever (2)
    • Louse-borne typhus (1)
    • Epidemic louse-borne typhus (1)
    • Quintan fever (1)
    • Fifth disease (1)
    • Piroplasmosis (1)
    • Sindbis fever (1)
    • Trench fever (1)
    • Ventilator-associated pneumonia (1)
    • Hand, foot and mouth disease (1)
    • Erythema infectiosum (1)
    • Babesiosis (1)
    • Anaplasmosis (1)
  • Public health area
    • Surveillance (3123)
    • Public health threat (1097)
    • Outbreak (1097)
    • Threats and outbreaks (1097)
    • Prevention and control (429)
    • Disease prevention (419)
    • Prophylaxis (419)
    • Active immunisation (392)
    • Vaccination (392)
    • Immunisation (392)
    • Scientific advice (380)
    • Antimicrobial resistance (371)
    • Antibiotic resistance (371)
    • Microbiology (357)
    • Epidemiology (347)
    • Epidemic (188)
    • Determinant (175)
    • Preparedness (156)
    • Health communication (152)
    • Public health response (100)
    • Control campaign (100)
    • Molecular typing (89)
    • Vaccination coverage (85)
    • Laboratories (82)
    • Antimicrobial consumption (82)
    • Migrant health (77)
    • Laboratory based surveillance (77)
    • Diagnostic test (68)
    • Infectious diseases on aircrafts (67)
    • Travellers' health (67)
    • Preventive measure (63)
    • Training (63)
    • Transmission of disease (58)
    • Climate change (53)
    • Mass gathering (42)
    • Vaccine safety (38)
    • Laboratory quality (36)
    • Pandemic preparedness (35)
    • Epidemic intelligence (34)
    • National reference laboratory (33)
    • Reference laboratory (33)
    • Vaccine effectiveness (32)
    • Case management (26)
    • Health inequality (22)
    • Vaccine efficacy (20)
    • Burden of communicable diseases (20)
    • Hospital infection control (19)
    • Vaccine hesitancy (19)
    • Laboratory capacity (17)
    • Public health education (16)
    • Antiviral (16)
    • Whole genome sequencing (16)
    • HIV testing (16)
    • Hand hygiene (14)
    • Pregnant women (14)
    • Crisis communication (12)
    • Injecting drug users (IDUs) (12)
    • Intravenous drug users (12)
    • Antimicrobial stewardship (12)
    • People who inject drugs (PWID) (12)
    • Risk communication (12)
    • Country cooperation (12)
    • High-risk groups (11)
    • Biosafety (10)
    • Personal protective equipment (10)
    • Risk assessment guidelines for infectious diseases transmitted on aircraft (RAGIDA) (9)
    • Multidrug resistance (8)
    • Childhood vaccination (8)
    • Community engagement (8)
    • Laboratory guideline (7)
    • Health literacy (6)
    • Blood safety (6)
    • Hospital hygiene (4)
    • Point prevalence survey (4)
    • Substance of human origin (4)
    • Social marketing (3)
    • Bioterrorism (3)
    • Outbreak communication (2)
    • Health advocacy (1)
    • Intensive care unit (ICU) (1)
  • Publication series
    • Communicable Disease Threats Report (CDTR) (458)
    • Annual Epidemiological Report on Communicable Diseases in Europe (285)
    • Influenza Virus Characterisation (93)
    • Monitoring Implementation of the Dublin Declaration (49)
    • Bi-annual measles and rubella monitoring report (36)
    • Monthly measles and rubella monitoring report (36)
    • Annual Report of the Director (25)
    • Tuberculosis surveillance in Europe (24)
    • The European Union One Health Zoonoses Report (14)
    • Avian influenza overview (14)
    • HIV/AIDS Surveillance in Europe (13)
    • Antimicrobial resistance surveillance in Europe (11)
    • Gonococcal antimicrobial susceptibility surveillance in Europe (10)
    • EU summary report on AMR in zoonotic bacteria (9)
    • Legionnaires’ disease in Europe (7)
    • Core competencies (6)
    • Sexually transmitted infections in Europe (5)
    • Migrant health series (5)
    • Surveillance of antimicrobial consumption in Europe (4)
    • Surveillance of invasive bacterial diseases (4)
    • Summary of key publications (3)
    • Annual threat report (2)
    • Multi-annual programme (2)
  • Country
    • Europe (3896)
    • Africa (283)
    • Asia (233)
    • Americas (147)
    • North America (62)
    • European Neighbourhood Policy countries (43)
    • EU Candidate Countries (18)
    • Pacific regions (16)
    • Indian Ocean (14)
    • Nothern Africa (10)
    • Oceania (10)
    • ENP (6)
    • EU Potential Candidates (1)
  • Media type
    • Publication (3631)
    • Data (2460)
    • Surveillance report (1211)
    • Map (1134)
    • Peer-reviewed publication (909)
    • Table (391)
    • Technical report (367)
    • Risk assessment (346)
    • Country profile (295)
    • Graph (263)
    • Corporate publication (174)
    • Infographic (150)
    • Technical guidance (142)
    • Tool (121)
    • Meeting report (91)
    • External quality assessment (77)
    • Factsheet (71)
    • Video (60)
    • Presentation (53)
    • Mission report (41)
    • Public health guidance (28)
    • Literature review (21)
    • Leaflet (21)
    • Poster (15)
    • Expert opinion (13)
    • Communication toolkit (10)
    • Systematic review (9)
    • Toolkit (7)
    • Case definition (5)
    • News (2)
    • Epidemiological update (2)
  • All (6091)
  • Publication (3631)
  • Data (2460)
  • Page 2 of 609 // 6081 Results found
    • Sort by:

Data

Data on the weekly subnational 14-day notification rate of new COVID-19 cases

Data - 21 Jan 2021

The downloadable data file contains information on the 14-day notification rate of new cases per 100 000 inhabitants for COVID-19 by day and subnational region. Each row contains the corresponding data for a certain epidemiological week and per subnational region. The file is updated weekly. You may use the data in line with ECDC’s copyright policy.

  • Coronavirus
  • COVID-19
  • Public health threat
  • Surveillance

Data

Data on the 14-day age-specific notification rate of new COVID-19 cases

Data - 21 Jan 2021

The downloadable data file contains information on the 14-day notification rate of newly reported COVID-19 cases per 100 000 population by age group, week and country. Each row contains the corresponding data for a certain week and country. The file is updated weekly. You may use the data in line with ECDC’s copyright policy.

Data

Data for the maps in support of the Council Recommendation on a coordinated approach to the restriction of free movement in response to the COVID-19 pandemic in the EU/EEA

Data - 14 Jan 2021

The downloadable data file contains the data on which the maps requested in the Council Recommendation on a coordinated approach to the restriction of free movement in response to the COVID-19 pandemic in EU/EEA are based. They are published every Thursday.

  • Coronavirus
  • COVID-19
  • EU/EEA
  • Public health threat
  • United Kingdom

Publication

Risk related to the spread of new SARS-CoV-2 variants of concern in the EU/EEA – first update

Risk assessment - 21 Jan 2021

This risk assessment presents the latest available information on the recent emergence of three variants of concern, VOC 202012/01 identified in the United Kingdom (UK), 501Y.V2 identified in South Africa, and P.1 identified in Brazil and Japan.

Risk related to the spread of new SARS-CoV-2 variants of concern in the EU/EEA – first update - EN - [PDF-1.46 MB]
  • Coronavirus
  • COVID-19
  • EU/EEA
  • Public health threat
  • Surveillance

Data

Infographic: Mutation of SARS-CoV2 - current variants of concern

Infographic - 21 Jan 2021

This infographic provides information on the three current variants of concern detected in the UK, South Africa, Brazil and Japan.

  • Brazil
  • Coronavirus
  • COVID-19
  • EU/EEA
  • Japan
  • Public health threat
  • South Africa
  • Surveillance
  • United Kingdom

Publication

Plague - Annual Epidemiological Report for 2019

Surveillance report - 20 Jan 2021

For 2019, no cases of plague were reported by any of the EU/EEA countries.

Plague - Annual Epidemiological Report for 2019 - EN - [PDF-239.45 KB]
  • Plague
  • Surveillance

Data

The Response Measures Database (RMD)

Tool - 20 Jan 2021

The ECDC-JRC database is an archive of non-pharmaceutical interventions (NPIs), or measures, introduced by 30 countries in the European Union and European Economic Area in response to the COVID-19 pandemic. It gives detailed information on Response Measures.

  • Coronavirus
  • COVID-19
  • Prevention and control
  • Preventive measure
  • Public health response
  • Public health threat

Publication

Sequencing of SARS-CoV-2 - first update

Technical guidance - 18 Jan 2021

This technical guidance aims to provide guidelines to laboratories and relevant stakeholders in the European Union (EU), European Economic Area (EEA) and other countries in the WHO European region in making decisions on establishing sequencing capacities and capabilities, in making decisions on which technologies to use and/or in deciding on the role of sequencing for SARS-CoV-2 diagnostics, research, outbreak investigations and surveillance.

Sequencing of SARS-CoV-2 - first update, 18 January 2021 - EN - [PDF-559.12 KB]
  • Coronavirus
  • COVID-19
  • Diagnostic test
  • EU/EEA
  • Laboratories
  • Laboratory based surveillance
  • Microbiology
  • Public health threat
  • Surveillance

Publication

Influenza virus characterisation, December 2020

Surveillance report - 18 Jan 2021

This is the third report for the 2020–2021 influenza season. As of week 53/2020, only 415 influenza detections across the WHO European Region had been reported; 50% type A viruses, with A(H3N2) prevailing over A(H1N1)pdm09, and 50% type B viruses with only four having been ascribed to a lineage, three B/Victoria and one B/Yamagata. This represents a 98% drop in detections compared to the same period in 2019, probably due to the COVID-19 pandemic and measures introduced to combat it.

Influenza virus characterisation, December 2020 - EN - [PDF-5.4 MB]
  • EU/EEA
  • Influenza
  • Influenza in humans, seasonal
  • Surveillance

Publication

ECDC rapid assessment of laboratory practices and needs related to COVID-19

Technical report - 18 Jan 2021

This report assesses the current status of the EU/EEA and the UK COVID-19 laboratory response based on a short survey sent to all Member States and the UK.

  • Coronavirus
  • COVID-19
  • EU/EEA
  • Laboratories
  • Laboratory capacity
  • Microbiology
  • Public health threat
  • Surveillance

Pagination

  • First page « First
  • Previous page ‹‹
  • Page 1
  • Current page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Next page ››
  • Last page Last »
  • About us

    • What we do
    • Who we are
    • Governance
  • Work with us

    • Vacancies
    • Fellowships
    • Traineeships
    • Procurement and grants
  • Contact ECDC

    • Visit us
    • ECDC press room
    • Social media
Log in to ECDC Extranet
Newsletter RSS

Follow us:

Facebook Twitter Youtube Linked In Vimeo Slide share

Footer Navigation

  • Legal notice
  • Copyright
  • Access to TESSy data
  • Personal data protection
  • Language policy
  • Cookie policy
  • Accessibility
  • Sitemap
© European Centre for Disease Prevention and Control (ECDC) 2021
  • Other sites:
    • ECDC
    • European Antibiotic Awareness Day
    • ESCAIDE - Scientific conference
    • Eurosurveillance journal
    • EVIP - Vaccination portal
  • Home
  • All topics: A to Z
  • News & events
  • Publications & data
  • Tools
  • About us